December 9, 2019 — DiA Imaging Analysis Ltd., an IBM Alpha Zone Accelerator Alumni Startup, announces a collaboration with IBM Watson Health, a leading provider of innovative AI, enterprise imaging, and interoperability solutions used by medical professionals worldwide. The IBM Imaging AI Marketplace will offer DiA’s FDA-cleared, AI-powered cardiac ultrasound software, designed to assist clinicians to analyze cardiac ultrasound images automatically.
Analyzing ultrasound images is often a visual process that can be challenging and highly dependent on user experience. DiA’s solutions address this challenge by assisting clinicians to objectively and accurately analyze ultrasound images, reducing the subjectivity associated with visual interpretation.
With the launch of the IBM Imaging AI Marketplace, IBM will be introducing DiA’s LVivo EF solution, one of several cardiology and general imaging AI solutions that the company has developed. DiA’s LVivo EF application offers clinicians an AI-based quantification solution that will provide automated clinical data such as Ejection Fraction (EF) and Global Longitudinal Strain (GLS). The company anticipates adding additional solutions to the Marketplace in the near future.
“IBM Watson Health is proud to announce a collaboration with DiA Imaging,” said Anne Le Grand, General Manager, Imaging, Life Sciences and Oncology, IBM Watson Health. “DiA’s innovative AI-powered offerings can provide our clients with the ability to analyze images with advanced AI-based solutions which can support IBM Watson Health’s mission to help build smarter health ecosystems.”
“Our collaboration with IBM Watson Health demonstrates the implementation of DiA’s vision to make the analysis of ultrasound images smarter and accessible to clinicians with various levels of experience, on any platform,” said Hila Goldman-Aslan, CEO and Co- Founder of DiA Imaging Analysis. “We are proud to offer our cross-platform, vendor-neutral solutions to healthcare providers in the IBM Watson Health’s ecosystem, leading the change to help transform ultrasound analysis with AI.”
DiA demonstrated its full suite of LVivo and additional solutions during the Radiological Society of North America’s (RSNA) 2019 annual meeting in Chicago. DiA’s AI was highlighted and demonstrated at the IBM Watson Health Booth.
For more information: www.dia-analysis.com
December 19, 2024 
